ABio Clinical Research Partners
New London, North Carolina, 28127, United States
Location status: Recruiting
NCT Number: NCT07388355
This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
New London, North Carolina, 28127, United States
Location status: Recruiting
Once eligibility is determined, participants will receive and apply the WearLinq patch for 7 consecutive days (or until an endpoint is met). A subset of subjects will be asked to participate in an Extended Use Cohort (30 days).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This device is a wearable multi-channel ECG monitoring device for continuous cardiac rhythm tracking.
Time frame: 7 Days
Days of use until one of the following is reached: patch no longer adheres, signal loss, voluntary removal, or 7 days is achieved
Time frame: 7 Days
Incidences of self-reported adverse events for the duration of the study
Contact information is provided by the study sponsor or research team.
Wearlinq
Industry
WearLinq eWave Patch Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07729839
Healthy Adult Participants
Guangzhou, Guangdong, China
View Trial DetailsNCT06429930
Cardiovascular Diseases, Healthy Adult Participants
Christchurch, New Zealand
View Trial DetailsNCT07715149
Healthy Adult Participants, Hepatic Impairment (HI)
Bengbu, Anhui, China
View Trial DetailsNCT07684534
CrossFit, Healthy Adult Participants
Murcia, Spain
View Trial Details